CXCL13 and neoplasm: We hypothesized that CXCL13-CXCR5 axis orchestrates tumor cell-stroma cell interactions that regulate functions of TILs within the TME, thereby modifying tumor development and progression, as well as determining responsiveness to immune-targeted therapies.